Fig. 1From: Real-world use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers/β-blocks in Chinese patients before acute myocardial infarction occurs: patient characteristics and hospital follow-upFlow chart of patient enrollment. AAβ angiotensin-converting-enzyme inhibitors (ACEI) or angiotensin-receptor blockers (ARB) or β-blockers (β-B), AMI acute myocardial infarction, MACE major adverse cardiovascular eventsBack to article page